Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Eichelbaum

Showing results (191-200 of 263) with videos related to

Pageof 27
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1994
Endogenous codeine and morphine in poor and extensive metabolisers of the CYP2D6 (debrisoquine/sparteine) polymorphismG Mikus, F Bochner, M Eichelbaum, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1990
Interaction of verapamil and cimetidine: stereochemical aspects of drug metabolism, drug disposition and drug actionG Mikus, M Eichelbaum, C Fischer, et al.
Klinische Wochenschrift|December 2, 1985
Pharmacokinetics of oral and intravenous rifampicin during chronic administrationU Loos, E Musch, J C Jensen, et al.
Biochemical Pharmacology|January 1, 1988
Stereoselective 4-hydroxylation of debrisoquine in NigeriansM S Lennard, G T Tucker, H F Woods, et al.
British Journal of Clinical Pharmacology|March 28, 1998
Gut wall metabolism of verapamil in older people: effects of rifampicin-mediated enzyme inductionM F Fromm, K Dilger, D Busse, et al.
Clinical Pharmacology and Therapeutics|April 1, 1997
Effect of codeine on gastrointestinal motility in relation to CYP2D6 phenotypeG Mikus, B Trausch, C Rodewald, et al.
Circulation|May 1, 1994
An enantiomer-enantiomer interaction of (S)- and (R)-propafenone modifies the effect of racemic drug therapyH K Kroemer, M F Fromm, K Bühl, et al.
Clinical Pharmacology and Therapeutics|May 1, 1985
Dissociation of co-regulatory control of debrisoquin/phenformin and sparteine oxidation in GhanaiansN M Woolhouse, M Eichelbaum, N S Oates, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 21, 2000
In vitro interaction of codeine and diclofenacS Ammon, O von Richter, U Hofmann, et al.
Pharmacogenetics|December 11, 1999
Consequences of rifampicin treatment on propafenone disposition in extensive and poor metabolizers of CYP2D6K Dilger, B Greiner, M F Fromm, et al.
Pageof 27

Showing results (191-200 of 263) with videos related to

Sort By:
Pageof 27
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1994
Endogenous codeine and morphine in poor and extensive metabolisers of the CYP2D6 (debrisoquine/sparteine) polymorphismG Mikus, F Bochner, M Eichelbaum, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1990
Interaction of verapamil and cimetidine: stereochemical aspects of drug metabolism, drug disposition and drug actionG Mikus, M Eichelbaum, C Fischer, et al.
Klinische Wochenschrift|December 2, 1985
Pharmacokinetics of oral and intravenous rifampicin during chronic administrationU Loos, E Musch, J C Jensen, et al.
Biochemical Pharmacology|January 1, 1988
Stereoselective 4-hydroxylation of debrisoquine in NigeriansM S Lennard, G T Tucker, H F Woods, et al.
British Journal of Clinical Pharmacology|March 28, 1998
Gut wall metabolism of verapamil in older people: effects of rifampicin-mediated enzyme inductionM F Fromm, K Dilger, D Busse, et al.
Clinical Pharmacology and Therapeutics|April 1, 1997
Effect of codeine on gastrointestinal motility in relation to CYP2D6 phenotypeG Mikus, B Trausch, C Rodewald, et al.
Circulation|May 1, 1994
An enantiomer-enantiomer interaction of (S)- and (R)-propafenone modifies the effect of racemic drug therapyH K Kroemer, M F Fromm, K Bühl, et al.
Clinical Pharmacology and Therapeutics|May 1, 1985
Dissociation of co-regulatory control of debrisoquin/phenformin and sparteine oxidation in GhanaiansN M Woolhouse, M Eichelbaum, N S Oates, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 21, 2000
In vitro interaction of codeine and diclofenacS Ammon, O von Richter, U Hofmann, et al.
Pharmacogenetics|December 11, 1999
Consequences of rifampicin treatment on propafenone disposition in extensive and poor metabolizers of CYP2D6K Dilger, B Greiner, M F Fromm, et al.
Pageof 27